BiomX to Present at Upcoming April Investor Events
BiomX (NYSE American: PHGE) announced that CEO Jonathan Solomon will present at two virtual investor events in April 2021. The first is the Jefferies Microbiome-Based Therapeutics Summit on April 22, available on-demand from 8:00 AM EDT. The second is the Ladenburg Thalmann R&D Showcase on April 29 at 1:00 PM EDT, where Solomon will discuss the acne landscape and the lead product candidate, BX001, alongside Dr. Leon Kircik. Webcasts can be accessed on the company’s website.
- None.
- None.
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer of BiomX, will be presenting at two upcoming virtual investor events in April.
Presentation Details:
Event: Jefferies Microbiome-Based Therapeutics Summit
Date: Thursday, April 22, 2021
Time: On-demand beginning at 8:00 AM EDT
Event: Ladenburg Thalmann R&D Showcase
Date: Thursday, April 29, 2021
Time: 1:00 PM EDT
Format: Mr. Solomon will be joined by Key Opinion Leader, Dr. Leon Kircik, to discuss the acne landscape and BiomX’s lead product candidate, BX001.
Live webcasts from the Jefferies Microbiome-Based Therapeutics Summit and Ladenburg Thalmann R&D Showcase will be accessible through the Investors section of the Company’s website at ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.
About BiomX
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
Additional information is available at www.biomx.com, the content of which does not form a part of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005248/en/
FAQ
When is the Jefferies Microbiome-Based Therapeutics Summit for BiomX?
What is the date and time of the Ladenburg Thalmann R&D Showcase for BiomX?
Who will join Jonathan Solomon at the Ladenburg Thalmann R&D Showcase?
How can I access the webcasts for BiomX's presentations?
What is BiomX's lead product candidate?
